Group 1 - The core viewpoint of the news is that Kuaihua Pharmaceutical (002737.SZ) reported its Q3 2025 results, highlighting the institutional investor holdings and changes in share ownership [1] - As of October 27, 2025, six institutional investors hold a total of 301 million shares of Kuaihua Pharmaceutical, representing 51.53% of the total share capital [1] - The institutional holding ratio decreased by 0.86 percentage points compared to the previous quarter [1] Group 2 - Among public funds, two funds increased their holdings, namely E Fund CSI Dividend ETF and China Merchants CSI Dividend ETF, with a slight increase in holding ratio [1] - One public fund, Southern CSI 1000 ETF, reduced its holdings, resulting in a slight decrease in holding ratio [1] - A total of 81 public funds did not disclose their holdings this quarter, including notable funds such as Huaxia CSI 1000 ETF and GF CSI 1000 ETF [1] Group 3 - From the perspective of foreign investment, one foreign fund, Hong Kong Central Clearing Limited, reduced its holdings, leading to a slight decrease in holding ratio [2]
机构风向标 | 葵花药业(002737)2025年三季度已披露持仓机构仅6家